ABT vs. CAH: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ABT and CAH, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
ABT dominates in value with a market cap of 231.49 billion USD, eclipsing CAH’s 36.59 billion USD by roughly 6.33×.
With betas of 0.74 for ABT and 0.67 for CAH, both show similar volatility profiles relative to the overall market.
| Symbol | ABT | CAH |
|---|---|---|
| Company Name | Abbott Laboratories | Cardinal Health, Inc. |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Medical - Devices | Medical - Distribution |
| CEO | Mr. Robert B. Ford | Mr. Jason M. Hollar |
| Price | 133.05 USD | 153.31 USD |
| Market Cap | 231.49 billion USD | 36.59 billion USD |
| Beta | 0.74 | 0.67 |
| Exchange | NYSE | NYSE |
| IPO Date | March 17, 1980 | August 4, 1983 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of ABT and CAH over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
The section examines key financial ratios to assess the valuation of ABT and CAH based on earnings, cash flow, sales, and book value. Pay attention to the following notable points where extreme values stand out.
- CAH carries a sub-zero price-to-book ratio of -12.48, indicating negative equity. In contrast, ABT (P/B 2.48) has positive book value.
| Symbol | ABT | CAH |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 17.22 | 23.62 |
| Forward PEG Ratio (TTM) | 1.73 | 1.95 |
| Price-to-Sales Ratio (P/S, TTM) | 5.47 | 0.16 |
| Price-to-Book Ratio (P/B, TTM) | 2.48 | -12.48 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 34.77 | 15.00 |
| EV-to-EBITDA (TTM) | 22.97 | 14.56 |
| EV-to-Sales (TTM) | 5.63 | 0.18 |
| EV-to-Free Cash Flow (TTM) | 35.78 | 16.79 |
Dividend Comparison
Both ABT and CAH offer similar dividend yields (1.71% vs. 1.32%), indicating comparable approaches to balancing income and growth.
| Symbol | ABT | CAH |
|---|---|---|
| Dividend Yield (TTM) | 1.71% | 1.32% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of ABT and CAH, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- CAH’s current ratio of 0.94 indicates its assets may not cover near-term debts, whereas ABT at 1.78 maintains healthy liquidity.
- CAH posts a quick ratio of 0.50, indicating limited coverage of short-term debts from its most liquid assets—while ABT at 1.27 enjoys stronger liquidity resilience.
- CAH has negative equity (debt-to-equity ratio -2.60), suggesting asset shortfalls, whereas ABT at 0.14 preserves healthier equity coverage.
| Symbol | ABT | CAH |
|---|---|---|
| Current Ratio (TTM) | 1.78 | 0.94 |
| Quick Ratio (TTM) | 1.27 | 0.50 |
| Debt-to-Equity Ratio (TTM) | 0.14 | -2.60 |
| Debt-to-Assets Ratio (TTM) | 0.16 | 0.15 |
| Interest Coverage Ratio (TTM) | 15.39 | 15.45 |